Potassium management with finerenone: Practical aspects

INTRODUCTION: Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, has favourable effects on cardiorenal outcomes in patients with mild‐to‐severe chronic kidney disease with increased albuminuria and type 2 diabetes. METHODS: Two large, randomized trials have evaluated the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanner, Christoph, Fioretto, Paola, Kovesdy, Csaba P., Malyszko, Jolanta, Pecoits‐Filho, Roberto, Schnell, Oliver, Rossignol, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659654/
https://www.ncbi.nlm.nih.gov/pubmed/36574588
http://dx.doi.org/10.1002/edm2.360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659654/
https://www.ncbi.nlm.nih.gov/pubmed/36574588
http://dx.doi.org/10.1002/edm2.360

Ejemplares similares